Dr. Reddy's Laboratories Share Price
Mid Cap | Pharmaceuticals and health care | NSE: DRREDDY | BSE: 500124
₹1,236.30 16.30 (1.34 %)
Last Updated: 15 May 2025 03:59 PM
Overview
Open (₹) 1,214.00
High (₹) 1,239.80
Low (₹) 1,200.20
Prev. Close (₹) 1,220.00
Volume 20,53,550
VWAP (₹) 1,182.01
ROCE (%) 21.81
Industry P/E 45.08
TTM P/E 19.21
P/B Ratio 3.07
Market Cap (₹) Cr.1,03,163.72
Dividend Yield (%)--
EPS (₹) 64.13
ROE15.94%
Sales Growth (%) 16.54
Profit Growth (%)2.52
Day Range
1,239.801,239.80
52 Week Range
1,025.901,420.20
Historical Returns
Returns (6M)
3.58 %
Returns (1Y)
5.66 %
Returns (3Y)
58.34 %
Returns (5Y)
68.01 %
Returns (6M)
3.58 %
Returns (1Y)
5.66 %
Returns (3Y)
58.34 %
Returns (5Y)
68.01 %
SWOT Analysis
- Company with Low Debt
- Increasing Annual Revenue for Past 2 Years
- Growth in Net Profit Margin (QoQ)
- Strong short-term momentum: Price above short-term moving averages (EMA_10)
- Bullish MACD crossover (12,6,9) indicates potential upward price movement.
- Positive ROC (9) indicates upward momentum.
- Strong trend indicated by ADX above 25.
- Price above the pivot point indicates bullish sentiment.
- Price above EMA and SMA (50) indicates bullish momentum.
Technicals
Technical Rating
RSI 54.32
MFI 71.60
ATR 31.13
Commodity Channel Index 65.58
ROC125 -9.81
ROC21 1.78
Williams %R -18.54
Resistance & Support
Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
---|---|---|---|---|---|---|---|
Current | 1,194.66 | 1,206.43 | 1,218.06 | 1,183.03 | 1,171.26 | 1,159.63 | 1,147.86 |
Week Ago | 1,203.64 | 1,232.47 | 1,254.44 | 1,181.67 | 1,152.84 | 1,130.87 | 1,102.04 |
Month Ago | 1,156.80 | 1,163.60 | 1,174.50 | 1,145.90 | 1,139.10 | 1,128.20 | 1,121.40 |
EMA & SMA
1236.30
Current Price
Bullish Moving Averages
18
Bearish Moving Averages
2
5 Day 1180.44
9 Day 1182.61
10 Day 1178.56
12 Day 1163.44
14 Day 1157.13
20 Day 1154.52
26 Day 1162.78
50 Day 1157.84
100 Day 1220.51
200 Day 1272.17
Deals & Announcements
Bulk and Block Deals
Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
---|---|---|---|---|---|---|
ISHARES CORE EMERGING MARKETS MAURITIUS CO | block | Sell | 14th Nov, 2022 | ₹4,539.45 | 1,80,717 | NSE |
ISHARES CORE MSCI EMERGING MARKETS ETF | block | Buy | 14th Nov, 2022 | ₹4,539.45 | 1,80,717 | NSE |
ISHARES CORE EMERGING MARKETS MAURITIUS CO | block | Sell | 3rd Nov, 2022 | ₹4,555.65 | 1,80,718 | NSE |
ISHARES CORE MSCI EMERGING MARKETS ETF | block | Buy | 3rd Nov, 2022 | ₹4,555.65 | 1,80,718 | NSE |
ISHARES CORE EMERGING MARKETS MAURITIUS CO | block | Sell | 3rd Oct, 2022 | ₹4,335.70 | 1,49,492 | NSE |
ISHARES CORE MSCI EMERGING MARKETS ETF | block | Buy | 3rd Oct, 2022 | ₹4,335.70 | 1,49,492 | NSE |
ISHARES INDIA MAURITIUS CO | block | Sell | 8th Aug, 2022 | ₹4,156.85 | 19,329 | NSE |
ISHARES INDIA INDEX MAURITIUS COMPANY | block | Sell | 8th Aug, 2022 | ₹4,156.85 | 1,37,595 | NSE |
ISHARES MSCI INDIA ETF | block | Buy | 8th Aug, 2022 | ₹4,156.85 | 1,37,595 | NSE |
ISHARES INDIA 50 ETF | block | Buy | 8th Aug, 2022 | ₹4,156.85 | 19,329 | NSE |
Insider Trading
Date | Name | Action | Avg. Price | Quantity | Deal Value |
---|---|---|---|---|---|
26th Sept, 2024 | Vincent Colicchio | Acquisition | ₹6,553.00 | 1,594 | NSE |
26th Sept, 2024 | Anjum Swaroop | Acquisition | ₹6,553.00 | 1,412 | NSE |
26th Sept, 2024 | C Swaminathan | Disposal | ₹6,651.41 | 1,700 | NSE |
4th Sept, 2024 | Bryan Dixon | Acquisition | ₹6,914.00 | 150 | NSE |
4th Sept, 2024 | Milan Kalawadia | Acquisition | ₹6,914.00 | 814 | NSE |
4th Sept, 2024 | Subba Inta | Acquisition | ₹6,914.00 | 704 | NSE |
4th Sept, 2024 | C Swaminathan | Acquisition | ₹6,914.72 | 1,250 | NSE |
4th Sept, 2024 | Juan Carlos Alvarez | Acquisition | ₹6,914.00 | 145 | NSE |
4th Sept, 2024 | Sanjay Choubey | Acquisition | ₹6,914.00 | 215 | NSE |
4th Sept, 2024 | Tricia Wetzel | Acquisition | ₹6,802.78 | 594 | NSE |
Corporate Actions
Announcement Date | Subject | Ex - Date | Record Date |
---|---|---|---|
27th Jul, 2024 | Stock Split from Rs. 5/- to Re. 1/- | 28th Oct, 2024 | 28th Oct, 2024 |
7th May, 2024 | Rs.40.0000 per share(800%)Final Dividend | 16th Jul, 2024 | 1st Jan, 1970 |
10th May, 2023 | Rs.40.0000 per share(800%)Final Dividend | 11th Jul, 2023 | 1st Jan, 1970 |
19th May, 2022 | Rs.30.0000 per share(600%)Final Dividend | 11th Jul, 2022 | 1st Jan, 1970 |
Announcements
Date | Source | Detail |
---|---|---|
9th May, 2025 | BSE India | Q4 & FY 2025 Audited Financial results presentation |
9th May, 2025 | BSE India | Incorporation of Step down Wholly-owned Subsidiary |
9th May, 2025 | BSE India | Audited Financial results for the quarter and year ended March 31, 2025 |
9th May, 2025 | BSE India | Grant of employee stock options |
9th May, 2025 | BSE India | Appointment of Secretarial Auditor of the Company |
9th May, 2025 | BSE India | 41st Annual General Meeting (AGM) of the members of the Company scheduled to be held on Thursday, July 24, 2025. |
9th May, 2025 | BSE India | Recommendation of final dividend |
9th May, 2025 | BSE India | Record date for purpose of determining the members eligible to receive the final dividend for the financial year ended March 31, 2025 is fixed as July 10, 2025 |
9th May, 2025 | BSE India | Recommendation of final dividend |
9th May, 2025 | BSE India | Re-appointment of Mr. G V Prasad, Whole-Time Director designated as Co-Chairman & Managing Director |
Board Meetings
Purpose | Details | Meeting Date | Broadcast Date |
---|---|---|---|
Audited Results, Dividend & Others | To consider other business matters. | 25th Mar, 2025 | 9th May, 2025 |
Quarterly Results | -- | 24th Dec, 2024 | 23rd Jan, 2025 |
Quarterly Results | -- | 1st Oct, 2024 | 5th Nov, 2024 |
Quarterly Results & Stock Split | -- | 24th Jul, 2024 | 27th Jul, 2024 |
Audited Results & Final Dividend | -- | 26th Mar, 2024 | 7th May, 2024 |
Quarterly Results | -- | 22nd Dec, 2023 | 30th Jan, 2024 |
Quarterly Results | -- | 26th Sept, 2023 | 27th Oct, 2023 |
Quarterly Results | -- | 11th Jul, 2023 | 26th Jul, 2023 |
Audited Results & Final Dividend | -- | 24th Mar, 2023 | 10th May, 2023 |
Quarterly Results | -- | 28th Dec, 2022 | 25th Jan, 2023 |
Share Holding Pattern
Owner Name | Mar, 2025 | Dec, 2024 | Dec, 2023 | Dec, 2022 | Dec, 2021 |
---|---|---|---|---|---|
Promoter Group | 26.64% | 26.64% | 26.65% | 26.7% | 26.72% |
Foreign Institutions + | 25.75% | 26.85% | 28.62% | 27.29% | 27.42% |
Domestic Institutions + | 37.17% | 36.12% | 33.98% | 33.91% | 22.29% |
Government | 0% | 0% | 0% | 0% | 0% |
Public | 10.15% | 10.23% | 10.57% | 11.85% | 23.29% |
Others | 0.29% | 0.16% | 0.18% | 0.25% | 0.28% |
About Dr. Reddy's Laboratories
Dr. Reddy's Laboratories is a Public Limited Listed company incorporated on 24/02/1984 and has its registered office in the State of Telangana, India. Company’s Corporate Identification Number(CIN) is L85195TG1984PLC004507 and registration number is 004507. Currently Company is involved in the business activities of Manufacture of other pharmaceutical and botanical products like hina powder etc.. Company’s Total Operating Revenue is Rs. 23115.40 Cr. and Equity Capital is Rs. 83.40 Cr. for the Year ended 31/03/2025.
Parent Organisation
Reddy Group
Founded
1984
Managing Director
-- --
NSE Symbol
DRREDDY
Dr. Reddy's Laboratories Management
Name | Designation |
---|---|
Mr. K Satish Reddy | Chairman |
Mr. G V Prasad | Co-Chairman & Manag. Director |
Dr. Claudio Albrecht | Independent Director |
Ms. Kalpana Morparia | Independent Director |
Mr. Leo Puri | Independent Director |
Ms. Shikha Sharma | Independent Director |
Mr. Sanjiv Mehta | Independent Director |
Mr. Arun M Kumar | Independent Director |
Dr. K P Krishnan | Independent Director |
Ms. Penny Wan | Independent Director |
Dr. Alpna Seth | Independent Director |
Peer Comparison
Stocks | Market Cap | Market Price | 52 Week Low-High |
---|---|---|---|
Sun Pharmaceutical Industries | ₹4,38,934.34 | ₹1,740.10 ₹1,708.20(1.87%) | ₹1,376.750 - ₹1,960.200 |
Divi's Laboratories | ₹1,62,042.02 | ₹6,214.50 ₹6,215.50(-0.02%) | ₹3,725.550 - ₹6,448.750 |
Cipla | ₹1,23,213.62 | ₹1,502.20 ₹1,494.80(0.50%) | ₹1,310.050 - ₹1,702.000 |
Torrent Pharmaceuticals | ₹1,10,170.76 | ₹3,265.00 ₹3,244.90(0.62%) | ₹2,513.050 - ₹3,589.950 |
Dr. Reddy's Laboratories | ₹98,707.73 | ₹1,236.30 ₹1,220.00(1.34%) | ₹1,025.900 - ₹1,420.200 |
FAQs on Dr. Reddy's Laboratories
What is the share price of Dr. Reddy's Laboratories?
The share price of Dr. Reddy's Laboratories on 15th May, 2025 is ₹ 1,236.30.
What is 52W high and 52W low share price of Dr. Reddy's Laboratories?
The highest and lowest 52W share prices of Dr. Reddy's Laboratories are ₹ 1420.200 and ₹ 1025.900
What is the market cap of Dr. Reddy's Laboratories?
The market capitalization of Dr. Reddy's Laboratories as of 15th May, 2025 is ₹ 1,03,163.72 Crores
What is the P/E ratio of Dr. Reddy's Laboratories?
The current P/E ratio of Dr. Reddy's Laboratories as of 15th May, 2025 is 45.08
What is the PB ratio of Dr. Reddy's Laboratories?
The PB ratio of Dr. Reddy's Laboratories as of 15th May, 2025 is 3.07
Top Gainers
₹150.10
₹125.30 (0.20%)
₹108.60
₹90.50 (0.20%)
₹110.78
₹92.32 (0.20%)
₹14.37
₹11.98 (0.20%)
Top Losers
₹269.00
₹316.50 (-0.15%)
₹392.90
₹436.40 (-0.10%)
₹0.50
₹0.62 (-0.19%)
₹664.60
₹771.65 (-0.14%)
Market Indices
Sensex
₹80,501.99
₹80,242.24 (0.00%)